Psilocybin and other psychedelics are not currently approved for the use of treatment, but can be studied within the context of a clinical trial. Our Center focuses on conducting research studies on psychedelics, which includes studying the potential therapeutic benefits and efficacy of psychedelics.

For more information, links to our current studies can be found here. Each link will provide additional information about the study and instructions on how to apply.

If our current studies do not apply to you, or you are unable to participate for any reason. We encourage you to keep an eye out for upcoming studies on our website, subscribing to our newsletter, and following us on Facebook and Twitter.

You can also search for studies conducted at other institutions on clinicaltrials.gov

All media inquiries can be directed to [email protected]. Please be sure to include information about your project.

Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), and obsessive compulsive disorder (OCD).

We will post more information about these studies on our website when they become available.

Information on our current studies can be found here.

Our current job openings can be found on the CPCR Careers page.

If you are interested in applying for a student internship, please apply here.

The field of psychedelics is growing, and quickly, too. If you are interested in a career in psychedelic research, you may be interested in reading an article written by Dr. Albert Garcia-Romeu, “Making your Mark in the Psychedelic Renaissance.” You may also check out R. Andrew Sewell’s article “So, you want to be a psychedelic researcher?” To see which labs are currently conducting clinical trials with psychedelics, search clinicaltrials.gov.

If you are interested in seeking out clinical training, we encourage you to search the web for the various psychedelic clinical training programs that currently exist.

Please direct all employment inquiries to [email protected], and include your resume.

In the United States, psilocybin-therapy is only currently legally available through an FDA approved clinical trial.

Research on psychedelic substances has grown rapidly over the past few years, thus there are a number of locations where the effects of psychedelic substances are being studied. To view a list of all ongoing psychedelic studies, visit clinicaltrials.gov and search key terms (e.g., psilocybin, MDMA, psychedelics, etc.). Then, click the “On Map” tab to search for studies near you. Each listing provides information about the study, the location, and contact information.

Generally, our clinical trials require multiple in-person visits, so people who live within reasonable driving distance are preferred. Some studies may accept individuals who live further away, which is assessed on a case by case basis. If you would like to learn more about travel for a particular study, please select the study from the drop down to the right and submit a contact form.

The Media section of our website contains many articles and podcasts in which researchers describe the most recent findings in psychedelic science and their implications. For more frequent updates, you can subscribe to our newsletter and follow us on Facebook and Twitter.

To view a list of all of our scientific papers, visit our publications page.

Yes! We have several online survey studies that healthy volunteers can help with. If you are interested in participating one of these, please click here to view our current survey studies.

We plan to conduct additional in-person clinical trials with healthy volunteers, and when we begin those studies, we will add them to our website and share information on our newsletter, Facebook, and Twitter.